ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Mammography Reports Complete; Breast Project to Continue

March 25, 1977

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board

February 3, 1989

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Ann Landers, Columnist Who Urged Support for Cancer Act, Dead

June 28, 2002